Case Note & Summary
The dispute involved the classification of two products manufactured by the appellant, M/s Dabur India Limited, namely 'Lal Tail' and 'Janam Ghunti', under the Central Excise Tariff. The Tribunal had classified 'Lal Tail' under Chapter 33.04 and remitted the classification of 'Janam Ghunti' back to the original authority for further examination. The Supreme Court found no error in the Tribunal's decision regarding 'Janam Ghunti', emphasizing the need for a detailed inquiry into its manufacturing process and composition. The court highlighted that Chapter Note 1(c) of Chapter 30 excludes aqueous distillates or solutions of essential oils from its purview, while Chapter Note 1(d) clarifies that preparations under Chapter 33 are not classified under Chapter 30, even if they possess therapeutic properties. The appellant argued that 'Janam Ghunti' is an extraction rather than a distillate or solution, necessitating further investigation. Regarding 'Lal Tail', the appellant presented evidence from Ayurvedic texts and prescriptions from doctors indicating its medicinal use. The Tribunal had previously ruled against the appellant based on the precedent set in Shree Baidyanath Ayurved Bhavan Ltd. v. Collector of Central Excise, which defined a medicament as something prescribed by a medical practitioner for limited use. The Supreme Court, however, noted that the Revenue did not provide evidence to counter the appellant's claims about 'Lal Tail'. The court reaffirmed that classification should rely on the popular understanding of the product rather than strict scientific definitions. Ultimately, the court set aside the Tribunal's decision regarding 'Lal Tail', classifying it as a medicament under Chapter 30, while allowing the appeal in part and remitting the matter of 'Janam Ghunti' for further inquiry.
Headnote
A) Central Excise - Classification of Goods - Medicament Classification - Central Excise Act, 1944, Chapter 30 - The court upheld the Tribunal's decision to remit the classification of 'Janam Ghunti' for further inquiry while affirming that 'Lal Tail' is classifiable as a medicament based on Ayurvedic principles and evidence provided. The court noted that the Revenue failed to prove that 'Lal Tail' is not understood as a medicament in common parlance (Paras 1-4).
Issue of Consideration
Whether the products 'Lal Tail' and 'Janam Ghunti' are classifiable as medicaments under the Central Excise Tariff.
Final Decision
The Supreme Court set aside the Tribunal's decision regarding 'Lal Tail', classifying it as a medicament under Chapter 30, while allowing the appeal in part and remitting the classification of 'Janam Ghunti' for further inquiry.
Law Points
- Classification of goods
- Medicament definition
- Burden of proof
- Popular meaning interpretation
- Ayurvedic products classification
